1. Luo, Y., Weibman, D., Halperin, J. M. & Li, X. A Review of Heterogeneity in Attention Deficit/Hyperactivity Disorder (ADHD). Front Hum Neurosci 13, 42 (2019).
2. Banaschewski, T. et al. Attention-Deficit/Hyperactivity Disorder: A Current Overview. Deutsches Aerzteblatt Online 114, 149–159 (2017).
3. Cortese, S. et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry 5, 727–738 (2018).
4. Molina, B. S. G. et al. The MTA at 8 Years. J Am Acad Child Adolesc Psychiatry 48, 484–500 (2009).
5. Pimenta, M. G., Brown, T., Arns, M. & Enriquez-Geppert, S. Treatment Efficacy and Clinical Effectiveness of EEG Neurofeedback as a Personalized and Multimodal Treatment in ADHD: A Critical Review. Neuropsych Dis Treat Volume 17, 637–648 (2021).
6. Atkinson, A. et al. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther 69, 89–95 (2001).
7. Olbrich, S., Dinteren, R. van & Arns, M. Personalized Medicine: Review and Perspectives of Promising Baseline EEG Biomarkers in Major Depressive Disorder and Attention Deficit Hyperactivity Disorder. Neuropsychobiology 72, 229–240 (2016).
8. Arns, M., Gordon, E. & Boutros, N. N. EEG Abnormalities Are Associated With Poorer Depressive Symptom Outcomes With Escitalopram and Venlafaxine-XR, but Not Sertraline: Results From the Multicenter Randomized iSPOT-D Study. Clin EEG Neurosci 48, 33–40 (2017).
9. Arns, M. et al. EEG alpha asymmetry as a gender-specific predictor of outcome to acute treatment with different antidepressant medications in the randomized iSPOT-D study. Clin Neurophysiol 127, 509–19 (2016).
10. Olbrich, S. & Arns, M. EEG biomarkers in major depressive disorder: Discriminative power and prediction of treatment response. Int Rev Psychiatr 25, 604–618 (2013).
11. Iseger, T. A. et al. EEG connectivity between the subgenual anterior cingulate and prefrontal cortices in response to antidepressant medication. Eur Neuropsychopharmacol 27, 301–312 (2017).
12. Dinteren, R. van et al. Utility of event-related potentials in predicting antidepressant treatment response: an iSPOT-D report. Eur Neuropsychopharmacol 25, 1981–1990 (2015).
13. Arns, M. et al. Electroencephalographic biomarkers as predictors of methylphenidate response in attention-deficit/hyperactivity disorder. Eur Neuropsychopharm 28, 881–891 (2018).
14. Orr, K. E. & McHugh, K. The new international neuroblastoma response criteria. Pediatr Radiol 49, 1433–1440 (2019).
15. Deng, K., Li, H. & Guan, Y. Treatment Stratification of Patients with Metastatic Castration-Resistant Prostate Cancer by Machine Learning. Iscience 23, 100804 (2020).
16. Kato, M. & Manabe, A. Treatment and biology of pediatric acute lymphoblastic leukemia. Pediatr Int 60, 4–12 (2018).
17. Vinne, N. van der et al. EEG biomarker informed prescription of antidepressants in MDD: a feasibility trial. Eur Neuropsychopharm (2021) doi:10.1016/j.euroneuro.2020.12.005.
18. Keizer, A. W. Standardization and Personalized Medicine Using Quantitative EEG in Clinical Settings. Clin Eeg Neurosci 1550059419874945 (2019) doi:10.1177/1550059419874945.
19. Clark, C. R. et al. Spontaneous alpha peak frequency predicts working memory performance across the age span. Int J Psychophysiol 53, 1–9 (2004).
20. Pahor, A. & Jaušovec, N. Making Brains run Faster: are they Becoming Smarter? Span J Psychology 19, E88 (2016).
21. Lindsley, D. B. BRAIN POTENTIALS IN CHILDREN AND ADULTS. Science 84, 354–354 (1936).
22. Smith, J. R. The Electroencephalogram During Normal Infancy and Childhood: II. The Nature of the Growth of the Alpha Waves. Pedagogical Seminary J Genetic Psychology 53, 455–469 (1938).
23. Arns, M. EEG-Based Personalized Medicine in ADHD: Individual Alpha Peak Frequency as an Endophenotype Associated with Nonresponse. J Neurother 16, 123–141 (2012).
24. Klimesch, W. EEG alpha and theta oscillations reflect cognitive and memory performance: a review and analysis. Brain Res Rev 29, 169–195 (1999).
25. Grandy, T. H. et al. Individual alpha peak frequency is related to latent factors of general cognitive abilities. Neuroimage 79, 10–18 (2013).
26. Rodriguez, G., Copello, F., Vitali, P., Perego, G. & Nobili, F. EEG spectral profile to stage Alzheimer’s disease. Clin Neurophysiol 110, 1831–1837 (1999).
27. Murphy, M. & Öngür, D. Decreased peak alpha frequency and impaired visual evoked potentials in first episode psychosis. Neuroimage Clin 22, 101693 (2019).
28. Yeum, T.-S. & Kang, U. G. Reduction in Alpha Peak Frequency and Coherence on Quantitative Electroencephalography in Patients with Schizophrenia. J Korean Med Sci 33, (2018).
29. Bazanova, O. M., Auer, T. & Sapina, E. A. On the Efficiency of Individualized Theta/Beta Ratio Neurofeedback Combined with Forehead EMG Training in ADHD Children. Front Hum Neurosci 12, 3 (2018).
30. Arns, M., Gunkelman, J., Breteler, M. & Spronk, D. EEG Phenotypes predict treatment outcome to stimulants in children with ADHD. J Integr Neurosci 07, 421–438 (2008).
31. Ulrich, G., Renfordt, E., Zeller, G. & Frick, K. Interrelation between Changes in the EEG and Psychopathology under Pharmacotherapy for Endogenous Depression. A contribution to the predictor question. Pharmacopsychiatry 17, 178–183 (1984).
32. Krepel, N. et al. A multicenter effectiveness trial of QEEG-informed neurofeedback in ADHD: Replication and treatment prediction. Neuroimage Clin 102399 (2020) doi:10.1016/j.nicl.2020.102399.
33. Yao, D. et al. Which Reference Should We Use for EEG and ERP practice? Brain Topogr 32, 530–549 (2019).
34. Hermens, D. F., Kohn, M. R., Clarke, S. D., Gordon, E. & Williams, L. M. Sex differences in adolescent ADHD: findings from concurrent EEG and EDA. Clin Neurophysiol (2005) doi:10.1016/j.clinph.2005.02.012.
35. Steele, M., Jensen, P. S. & Quinn, D. M. P. Remission versus response as the goal of therapy in ADHD: A new standard for the field? Clin Ther 28, 1892–1908 (2006).
36. SWANSON, J. M. et al. Clinical Relevance of the Primary Findings of the MTA: Success Rates Based on Severity of ADHD and ODD Symptoms at the End of Treatment. J Am Acad Child Adolesc Psychiatry 40, 168–179 (2001).
37. Loo, S. K. et al. Effects of d-Methylphenidate, Guanfacine, and Their Combination on Electroencephalogram Resting State Spectral Power in Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry 55, 674-682.e1 (2016).
38. Group, T. N. C. et al. Double-blind placebo-controlled randomized clinical trial of neurofeedback for attention-deficit/hyperactivity disorder with 13 month follow-up. J Am Acad Child Adolesc Psychiatry (2020) doi:10.1016/j.jaac.2020.07.906.
39. Arns, M. et al. Neurofeedback and Attention-Deficit/Hyperactivity-Disorder (ADHD) in Children: Rating the Evidence and Proposed Guidelines. Appl Psychophys Biof 45, 39–48 (2020).
40. Bellato, A., Arora, I., Hollis, C. & Groom, M. J. Is autonomic nervous system function atypical in attention deficit hyperactivity disorder (ADHD)? A systematic review of the evidence. Neurosci Biobehav Rev 108, 182–206 (2020).
41. Musser, E. D. et al. Emotion Regulation via the Autonomic Nervous System in Children with Attention-Deficit/Hyperactivity Disorder (ADHD). J Abnorm Child Psych 39, 841–852 (2011).
42. Leikauf, J. E. et al. Identification of biotypes in Attention-Deficit/Hyperactivity Disorder, a report from a randomized, controlled trial. Personalized Medicine Psychiatry 3, 8–17 (2017).
43. Morris, S. S. J. et al. Emotion Regulation via the Autonomic Nervous System in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): Replication and Extension. J Abnorm Child Psych 48, 361–373 (2020).
44. Nir, R.-R., Sinai, A., Raz, E., Sprecher, E. & Yarnitsky, D. Pain assessment by continuous EEG: Association between subjective perception of tonic pain and peak frequency of alpha oscillations during stimulation and at rest. Brain Res 1344, 77–86 (2010).
45. Boord, P. et al. Electroencephalographic slowing and reduced reactivity in neuropathic pain following spinal cord injury. Spinal Cord 46, 118–123 (2008).
46. Sarnthein, J., Stern, J., Aufenberg, C., Rousson, V. & Jeanmonod, D. Increased EEG power and slowed dominant frequency in patients with neurogenic pain. Brain 129, 55–64 (2006).
47. Luijtelaar, G. van, Verbraak, M., Bunt, M. van den, Keijsers, G. & Arns, M. EEG Findings in Burnout Patients. J Neuropsychiatry Clin Neurosci 22, 208–217 (2010).
48. Wahbeh, H. & Oken, B. S. Peak High-Frequency HRV and Peak Alpha Frequency Higher in PTSD. Appl Psychophys Biof 38, 57–69 (2013).
49. Challman, T. D. & Lipsky, J. J. Methylphenidate: Its Pharmacology and Uses. Mayo Clin Proc 75, 711–721 (2000).
50. Bodenmann, S. et al. The Functional Val158Met Polymorphism of COMT Predicts Interindividual Differences in Brain α Oscillations in Young Men. J Neurosci 29, 10855–10862 (2009).
51. Veth, C. P. M. et al. Association between COMT Val158Met genotype and EEG alpha peak frequency tested in two independent cohorts. Psychiat Res 219, 221–4 (2014).
52. Sterman, M. B., Howe, R. C. & Macdonald, L. R. Facilitation of Spindle-Burst Sleep by Conditioning of Electroencephalographic Activity While Awake. Science 167, 1146–1148 (1970).
53. Arns, M., Feddema, I. & Kenemans, J. L. Differential effects of theta/beta and SMR neurofeedback in ADHD on sleep onset latency. Front Hum Neurosci 8, 1019 (2014).
54. Arns, M. & Kenemans, J. L. Neurofeedback in ADHD and insomnia: Vigilance stabilization through sleep spindles and circadian networks. Neurosci Biobehav Rev 44, 183–194 (2014).
55. Golan, N., Shahar, E., Ravid, S. & Pillar, G. Sleep Disorders and Daytime Sleepiness in Children with Attention-Deficit/ Hyperactive Disorder. Sleep 27, 261–266 (2004).
56. Pressman, M. R. & Fry, J. M. Relationship of Autonomic Nervous System Activity to Daytime Sleepiness and Prior Sleep. Sleep 12, 239–245 (1989).
57. Bedard, K. & Witman, A. Family structure and the gender gap in ADHD. Rev Econ Household 18, 1101–1129 (2020).
58. Corlier, J. et al. The relationship between individual alpha peak frequency and clinical outcome with repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder (MDD). Brain Stimul (2019) doi:10.1016/j.brs.2019.07.018.
59. Roelofs, C. et al. Individual alpha frequency proximity associated with repetitive transcranial magnetic stimulation outcome: An independent replication study from the ICON-DB consortium. Clin Neurophysiol (2020) doi:10.1016/j.clinph.2020.10.017.
60. Griffiths, K. R. et al. Response inhibition and emotional cognition improved by atomoxetine in children and adolescents with ADHD: The ACTION randomized controlled trial. J Psychiatr Res 102, 57–64 (2018).
61. Hunter, J. D. Matplotlib: A 2D graphics environment. Comput Sci Eng 9, 90--95 (2007).
62. Virtanen, P. et al. SciPy 1.0: Fundamental Algorithms for Scientific Computing in Python. Nature Methods 17, 261–272 (2020).
63. Harris, C. R., Millman, K. J., Walt, S. J. van der & al., et. Array programming with NumPy. Nature 585, 357–362 (2020).
64. team, T. pandas development. pandas-dev/pandas. (Zenodo, 2020).
65. McCracken, J. T. et al. Combined Stimulant and Guanfacine Administration in Attention-Deficit/Hyperactivity Disorder: A Controlled, Comparative Study. J Am Acad Child Adolesc Psychiatry 55, 657-666.e1 (2016).
66. Gerrits, B. et al. Probing the “Default Network Interference Hypothesis” With EEG: An RDoC Approach Focused on Attention. Clin EEG Neurosci 50, 404–412 (2019).
67. Dinteren, R. van, Arns, M., Jongsma, M. L. A. & Kessels, R. P. C. Combined frontal and parietal P300 amplitudes indicate compensated cognitive processing across the lifespan. Front Aging Neurosci 6, 294 (2014).